Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-10

FDA Approved: TESTOSTERONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved a supplemental application for a testosterone product from Padagis Israel Pharmaceuticals Ltd (ANDA204255).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

SUPPL AP for TESTOSTERONE (TESTOSTERONE)